Northwestern Mutual Wealth Management
AKBA icon

Northwestern Mutual Wealth Management’s Akebia Therapeutics AKBA Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$207 Buy
+149
New +$205 ﹤0.01% 3938
2025
Q4 		– Sell
-748
Closed -$2.04K – 4011
2025
Q3 		$2.04K Buy
+748
New +$2.49K ﹤0.01% 3383
2025
Q2 		– Sell
-5
Closed -$10 – 3662
2025
Q1 		$10 Buy
+5
New +$10 ﹤0.01% 3622
2023
Q1 		– Sell
-374
Closed -$216 – 3352
2022
Q4 		$216 Buy
+374
New +$117 ﹤0.01% 3179

Other funds holding AKBA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Northwestern Mutual Wealth Management's AKBA Position: Q1 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Akebia Therapeutics (AKBA) in Q1 2026: 149 shares worth $207. The stake represents ﹤0.01% of the portfolio and ranks #3938 among its holdings. This is a return to the name: Northwestern Mutual Wealth Management previously reported a position in AKBA as recently as Q3 2025.

Northwestern Mutual Wealth Management first reported a position in AKBA in Q4 2022 and has held it in 4 quarters since. The position peaked at $2.04K in Q3 2025. 171 funds tracked by Wall St. Rank hold AKBA as of Q1 2026.

  • Northwestern Mutual Wealth Management held 149 shares of Akebia Therapeutics worth $207 as of Q1 2026.
  • Akebia Therapeutics was a new Northwestern Mutual Wealth Management position in Q1 2026.
  • Akebia Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3938 holding.
  • Northwestern Mutual Wealth Management first reported a position in Akebia Therapeutics in Q4 2022 and has held it in 4 quarters since.
  • Northwestern Mutual Wealth Management's Akebia Therapeutics position peaked at $2.04K in Q3 2025.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.